Drugmakers oppose new drug-pricing plan

Published: 2010-02-18 06:59:00

Updated: 2010-02-18 06:59:00

Pharmaceutical companies are vehemently opposing to the government’s plan to provide doctors with incentives in terms of pricing, which was made public on February 16.

The Korea Pharmaceutical Manufacturers Association said in a press release that inducing hospitals and doctors to give out dis...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK